{"id":"W4243495076","doi":"10.1007/bf03294092","title":"Ranibizumab launched for wet AMD in Canada","year":2007,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Launched; Medicine; Ranibizumab; Pharmacy; Optometry; Family medicine; Internal medicine; Engineering","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005846978,0.0002240117,0.0002437531,0.0006871043,0.001276269,0.001424401,0.0004543441,0.0006231376,0.007232503],"category_scores_gemma":[0.0009586493,0.0001671523,0.0003144593,0.0006310474,0.0004382446,0.0002098575,0.0003698508,0.001036707,0.0008587983],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.02108239,"about_ca_system_score_gemma":0.04940623,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9066964,"about_ca_topic_score_gemma":0.9491626,"domain_scores_codex":[0.9994179,0.00003528731,0.00001910346,0.0000400916,0.0002419718,0.0002456867],"domain_scores_gemma":[0.9989723,0.00004479916,0.00004842055,0.00001405314,0.0005906934,0.0003296726],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01055859,0.0008324765,0.07068723,0.001045782,0.0003285747,0.009205097,0.001057979,0.001701965,0.07843708,0.01637045,0.2598789,0.5498959],"study_design_scores_gemma":[0.001572632,0.001456592,0.1872413,0.0002743618,0.0002606566,0.002011726,0.0007920425,0.001520405,0.02255628,0.0006095362,0.7816449,0.00005950292],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"commentary","genre_scores_codex":[0.5362244,0.04657388,0.003214094,0.04989092,0.003323727,0.001284231,0.01065339,0.001004011,0.3478313],"genre_scores_gemma":[0.8205469,0.01070967,0.003119828,0.006428438,0.0003673105,0.00009441165,0.00327915,0.0001422697,0.155312],"genre_candidate":"commentary","genre_consensus":null,"teacher_disagreement_score":0.09330362,"threshold_uncertainty_score":0.1877062,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02399687203799516,"score_gpt":0.2978639473308365,"score_spread":0.2738670752928414,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}